BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
BioCryst Pharmaceuticals Inc
Net Issuance of Common Stock
BioCryst Pharmaceuticals Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
Net Issuance of Common Stock
$5.3m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-15%
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-18%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$719m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-2%
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$288.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is BioCryst Pharmaceuticals Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
5.3m
USD
Based on the financial report for Mar 31, 2024, BioCryst Pharmaceuticals Inc's Net Issuance of Common Stock amounts to 5.3m USD.
What is BioCryst Pharmaceuticals Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-15%
Over the last year, the Net Issuance of Common Stock growth was -58%. The average annual Net Issuance of Common Stock growth rates for BioCryst Pharmaceuticals Inc have been -64% over the past three years , -38% over the past five years , and -15% over the past ten years .